Virax Biolabs (VRAX) Current Assets (2021 - 2023)

Virax Biolabs (VRAX) has 3 years of Current Assets data on record, last reported at $9.6 million in Q1 2023.

  • For Q1 2023, Current Assets rose 19679.93% year-over-year to $9.6 million; the TTM value through Mar 2023 reached $9.6 million, up 19679.93%, while the annual FY2023 figure was $9.6 million, 19679.93% up from the prior year.
  • Current Assets reached $9.6 million in Q1 2023 per VRAX's latest filing, up from $48706.0 in the prior quarter.
  • Across five years, Current Assets topped out at $9.6 million in Q1 2023 and bottomed at $39621.0 in Q1 2021.
  • Average Current Assets over 3 years is $3.2 million, with a median of $48706.0 recorded in 2022.
  • Peak YoY movement for Current Assets: rose 22.93% in 2022, then soared 19679.93% in 2023.
  • A 3-year view of Current Assets shows it stood at $39621.0 in 2021, then grew by 22.93% to $48706.0 in 2022, then skyrocketed by 19679.93% to $9.6 million in 2023.
  • Per Business Quant database, its latest 3 readings for Current Assets were $9.6 million in Q1 2023, $48706.0 in Q1 2022, and $39621.0 in Q1 2021.